A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma
- PMID: 26176864
- DOI: 10.1111/pcmr.12394
A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical